NPI: 1699166926 · BROOKLYN, NY 11219 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/09/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (ASSISTANT SECRETARY) |
| NPI Enumeration Date | 02/09/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,916 | $495K |
| 2019 | 20,296 | $832K |
| 2020 | 22,771 | $976K |
| 2021 | 19,552 | $977K |
| 2022 | 8,742 | $428K |
| 2024 | 1,584 | $131K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| A4657 | Syringe, with or without needle, each | 51,606 | 1,869 | $2.48M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 5,093 | 507 | $1.25M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 27,260 | 894 | $100K |
| 82728 | 2,018 | 225 | $3K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 166 | 31 | $3K |
| 83970 | 792 | 167 | $2K | |
| 82108 | 600 | 57 | $1K | |
| 85041 | 326 | 54 | $815.07 |